< Kenko Prostate
Prostate cancer is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer death among men. Prostate MRI plays a central role in detection, localisation, and risk assessment, particularly for clinically significant disease however, its interpretation remains complex, time, consuming, and highly dependent on radiologist expertise.
A multiparametric prostate MRI exam generates hundreds of images across sequences such as T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) MRI. Radiologists must integrate multiple signal patterns under time pressure, often relying on qualitative frameworks. As imaging demand increases and specialist capacity remains limited, variability and uncertainty continue to create a bottleneck in prostate cancer pathways.
Kenko Prostate addresses this challenge by transforming multiparametric MRI into quantitative, explainable imaging biomarkers that are visual, objective, and clinically interpretable. It provides structured insights into tumour presence, localisation, and biological behaviour, supporting radiologists in reducing reading time, improving consistency, and strengthening confidence in clinically significant cases.
The result is more robust risk stratification, clearer multidisciplinary communication, and more efficient, evidence-based prostate cancer care.
Kenko Prostate integrates seamlessly into routine Prostate MRI interpretation, supporting radiologists without changing how exams are acquired or read. After MRI acquisition, the radiologist securely uploads the multiparametric MRI study to Kenko Prostate, where the system processes the full exam and generates quantitative, explainable imaging biomarker maps and structured outputs.
Radiologists review these biomarker maps alongside the original MRI images, enabling clearer lesion characterisation, more consistent interpretation, and stronger evidence for multidisciplinary tumour board discussions. By transforming complex MRI data into visually interpretable, physiology-linked insights, Kenko Prostate helps radiologists move from image overload to quantitative clarity while maintaining full clinical control over interpretation and reporting.
From detection to understanding tumour behaviour
Understanding vascular behaviour
Dynamic contrast-enhanced MRI captures how blood flows through tissue. Kenko analyses both standard and ultrafast contrast dynamics to identify patterns associated with tumour vascularisation and aggressiveness. Early contrast uptake behaviour provides valuable insights into tumour activity and helps distinguish suspicious lesions.
Understanding tissue cellularity
Prostate tissue has an isotropic structure that is analysed through DWI, which is further translated by Kenko Prostate into physiological behaviours and corresponding imaging biomarkers that reflect both tissue cellularity and pseudo perfusion; at the same time reducing noise and improving robustness, which makes Kenko Prostate diffusion information clinically usable for prostate MRI interpretation.
Understanding vascular behaviour
Contrast-enhanced MRI captures how blood flows through tissue. Kenko analyses both standard and ultrafast contrast dynamics to identify patterns associated with tumour vascularisation and aggressiveness. Early contrast uptake behaviour provides valuable insights into tumour activity and helps distinguish suspicious lesions.
Understanding tissue cellularity
Prostate tissue has an anisotropic structure that is not fully captured by conventional diffusion imaging. Kenko uses diffusion tensor imaging (DWI) and advanced modelling to extract stable biomarkers that reflect tissue cellularity and structural organisation. By reducing noise and improving robustness, Kenko makes diffusion information clinically usable for Prostate MRI interpretation.
Kenko Prostate provides a set of clinically focused functionalities designed to support radiologists in Prostate MRI interpretation, reporting, and multidisciplinary decision-making through the interpretable use of quantitative imaging biomarkers derived from multiparametric MRI.
Converts Prostate MRI into pixel-wise quantitative imaging biomarker maps reflecting key tissue properties such as cellularity and vascular behaviour, enabling objective and reproducible assessment beyond qualitative visual MRI reading.
Performs integrated analysis of dynamic contrast-enhanced sequences, charaterising vascular behavior across temporal phases of contrast uptake and washout, extracting out the structural noise induced by the MR equipment.
Processes diffusion weighted sequences, characterizing the curves in terms of pure diffusion (low exponential decays) and pseudo-perfusion (fast exponential decays), extracting clinically meaningful imaging biomarkers rented to tissue cellularity.
Allows radiologists to navigate synchronously across biomarker maps derived from multiple MRI sequences, ensuring consistent spatial correspondence during image review.
Provides volumetric visualisation of quantitative biomarker maps to assess tumour extent, spatial distribution and heterogeneity.
Generates maximum intensity projection views of biomarker maps and allows radiologists to define the slice range used for projection.
Supports quantitative characterisation of Prostate lesions and surrounding tissue based on imaging biomarker maps derived from multiparametric MRI.
Your login details have been sent to the email address linked to your authorised account. Please
follow the instructions included in that email to
access the platform securely.
Thank you.
